Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043316108> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2043316108 endingPage "124" @default.
- W2043316108 startingPage "119" @default.
- W2043316108 abstract "OBJECTIVE: To compare the effect of repaglinide in combination with metformin with monotherapy of each drug on glycemic control in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: A total of 83 patients with type 2 diabetes who had inadequate glycemic control (HbA1c > 7.1%) when receiving the antidiabetic agent metformin were enrolled in this multicenter, double-blind trial. Subjects were randomized to continue with their prestudy dose of metformin (n = 27), to continue with their prestudy dose of metformin with the addition of repaglinide (n = 27), or to receive repaglinide alone (n = 29). For patients receiving repaglinide, the optimal dose was determined during a 4- to 8-week titration and continued for a 3-month maintenance period. RESULTS: In subjects receiving combined therapy, HbA1c was reduced by 1.4 +/- 0.2%, from 8.3 to 6.9% (P = 0.0016) and fasting plasma glucose by 2.2 mmol/l (P = 0.0003). No significant changes were observed in subjects treated with either repaglinide or metformin monotherapy in HbA1c (0.4 and 0.3% decrease, respectively) or fasting plasma glucose (0.5 mmol/l increase and 0.3 mmol/l decrease respectively). Subjects receiving repaglinide either alone or in combination with metformin, had an increase in fasting levels of insulin between baseline and the end of the trial of 4.04 +/- 1.56 and 4.23 +/- 1.50 mU/l, respectively (P < 0.02). Gastrointestinal adverse events were common in the metformin group. An increase in body weight occurred in the repaglinide and combined therapy groups (2.4 +/- 0.5 and 3.0 +/- 0.5 kg, respectively; P < 0.05). CONCLUSIONS: Combined metformin and repaglinide therapy resulted in superior glycemic control compared with repaglinide or metformin monotherapy in patients with type 2 diabetes whose glycemia had not been well controlled on metformin alone. Repaglinide monotherapy was as effective as metformin monotherapy." @default.
- W2043316108 created "2016-06-24" @default.
- W2043316108 creator A5008037752 @default.
- W2043316108 creator A5013439156 @default.
- W2043316108 creator A5034143880 @default.
- W2043316108 creator A5046889681 @default.
- W2043316108 creator A5048766379 @default.
- W2043316108 creator A5054247657 @default.
- W2043316108 creator A5068469433 @default.
- W2043316108 creator A5080414613 @default.
- W2043316108 creator A5084576521 @default.
- W2043316108 date "1999-01-01" @default.
- W2043316108 modified "2023-09-27" @default.
- W2043316108 title "Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes." @default.
- W2043316108 doi "https://doi.org/10.2337/diacare.22.1.119" @default.
- W2043316108 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10333912" @default.
- W2043316108 hasPublicationYear "1999" @default.
- W2043316108 type Work @default.
- W2043316108 sameAs 2043316108 @default.
- W2043316108 citedByCount "234" @default.
- W2043316108 countsByYear W20433161082012 @default.
- W2043316108 countsByYear W20433161082013 @default.
- W2043316108 countsByYear W20433161082014 @default.
- W2043316108 countsByYear W20433161082015 @default.
- W2043316108 countsByYear W20433161082016 @default.
- W2043316108 countsByYear W20433161082017 @default.
- W2043316108 countsByYear W20433161082018 @default.
- W2043316108 countsByYear W20433161082019 @default.
- W2043316108 countsByYear W20433161082020 @default.
- W2043316108 countsByYear W20433161082022 @default.
- W2043316108 countsByYear W20433161082023 @default.
- W2043316108 crossrefType "journal-article" @default.
- W2043316108 hasAuthorship W2043316108A5008037752 @default.
- W2043316108 hasAuthorship W2043316108A5013439156 @default.
- W2043316108 hasAuthorship W2043316108A5034143880 @default.
- W2043316108 hasAuthorship W2043316108A5046889681 @default.
- W2043316108 hasAuthorship W2043316108A5048766379 @default.
- W2043316108 hasAuthorship W2043316108A5054247657 @default.
- W2043316108 hasAuthorship W2043316108A5068469433 @default.
- W2043316108 hasAuthorship W2043316108A5080414613 @default.
- W2043316108 hasAuthorship W2043316108A5084576521 @default.
- W2043316108 hasConcept C126322002 @default.
- W2043316108 hasConcept C134018914 @default.
- W2043316108 hasConcept C2777180221 @default.
- W2043316108 hasConcept C2779306644 @default.
- W2043316108 hasConcept C2779463123 @default.
- W2043316108 hasConcept C2780323712 @default.
- W2043316108 hasConcept C2780473172 @default.
- W2043316108 hasConcept C2781281211 @default.
- W2043316108 hasConcept C555293320 @default.
- W2043316108 hasConcept C71924100 @default.
- W2043316108 hasConcept C90924648 @default.
- W2043316108 hasConceptScore W2043316108C126322002 @default.
- W2043316108 hasConceptScore W2043316108C134018914 @default.
- W2043316108 hasConceptScore W2043316108C2777180221 @default.
- W2043316108 hasConceptScore W2043316108C2779306644 @default.
- W2043316108 hasConceptScore W2043316108C2779463123 @default.
- W2043316108 hasConceptScore W2043316108C2780323712 @default.
- W2043316108 hasConceptScore W2043316108C2780473172 @default.
- W2043316108 hasConceptScore W2043316108C2781281211 @default.
- W2043316108 hasConceptScore W2043316108C555293320 @default.
- W2043316108 hasConceptScore W2043316108C71924100 @default.
- W2043316108 hasConceptScore W2043316108C90924648 @default.
- W2043316108 hasIssue "1" @default.
- W2043316108 hasLocation W20433161081 @default.
- W2043316108 hasLocation W20433161082 @default.
- W2043316108 hasOpenAccess W2043316108 @default.
- W2043316108 hasPrimaryLocation W20433161081 @default.
- W2043316108 hasRelatedWork W1594064718 @default.
- W2043316108 hasRelatedWork W2005477647 @default.
- W2043316108 hasRelatedWork W2010426891 @default.
- W2043316108 hasRelatedWork W2017026431 @default.
- W2043316108 hasRelatedWork W2043316108 @default.
- W2043316108 hasRelatedWork W2063868487 @default.
- W2043316108 hasRelatedWork W2073977015 @default.
- W2043316108 hasRelatedWork W2131463267 @default.
- W2043316108 hasRelatedWork W2159836149 @default.
- W2043316108 hasRelatedWork W4248476366 @default.
- W2043316108 hasVolume "22" @default.
- W2043316108 isParatext "false" @default.
- W2043316108 isRetracted "false" @default.
- W2043316108 magId "2043316108" @default.
- W2043316108 workType "article" @default.